GlaxoSmithKline Consumer Nigeria Plc released its Q3 2022 Unaudited results for the period ended September 30th, 2022.
Key Highlights
- Revenue grew by 24.15% from N16.45bn to N20.43bn.
- Profit before tax stood at N716.36m
- Profit after tax stood at N483.54m
- Share Price Currently Stands at N6.25k